Novel pediatric TB diagnostics using host and microbial biomarkers

The National Institute of Allergy and Infectious Diseases awarded Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, $672,540 on April 17, 2026, for novel pediatric tuberculosis diagnostics using host and microbial biomarkers under the Allergy and Infectious Diseases Research program (CFDA 93.855).

The project develops diagnostic tools to address tuberculosis as a leading cause of death in children worldwide, with children accounting for an estimated 14 percent of global TB deaths and 96 percent of these deaths going undiagnosed. Work is performed in Newark, New Jersey with a completion date of March 31, 2028. The award is a Project Grant, a standard assistance type under the program that supports biomedical research and research training in infectious diseases and related areas at nonprofit institutions.

Abstract

/summary tuberculosis (TB) is a leading cause of death in children worldwide, with children contributing to an estimated 14% of global TB deaths and 96% of these deaths being undiagnosed. Children